library.onepin.app/berberine Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Metabolic Dietary supplement

Berberine

Berberine HCl · Berberine Hydrochloride

500mg – 500 mg Oral 2-3x daily with meals

Berberine is a naturally occurring isoquinoline alkaloid found in several plants including goldenseal (Hydrastis canadensis), barberry (Berberis vulgaris), Oregon grape, and Chinese goldthread (Coptis chinensis). It has been used in Traditional Chinese Medicine and Ayurveda for over 2,500 years, primarily for gastrointestinal infections and diarrhea. In modern integrative medicine, berberine has emerged as one of the most evidence-backed natural compounds for metabolic health.

Quick Start
Route
Oral
Start low
500mg Oral
Frequency
2-3x daily with meals
Timing
Anytime

Take with meals (reduces GI side effects and matches carbohydrate exposure). Start with 500mg once daily for 1 week, then increase to 500mg 2-3x daily. Total daily dose typically 1000-1500mg.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
500mg · Oral · 2-3x daily with meals
conservative starter
500mg
2-3x daily with meals
Standard
Glycemic Control
500 mg · Oral · 3x Daily
human clinical trial · Yin et al. 2008 (Metabolism)
GI upset is common; ease into the 3x daily protocol.
500 mg
3x Daily
01

How it works

Berberine's primary mechanism is activation of AMP-activated protein kinase (AMPK), a cellular energy sensor that regulates glucose and lipid metabolism. AMPK activation increases glucose uptake in muscle cells (via GLUT4 translocation), enhances fatty acid oxidation, reduces hepatic gluconeogenesis, and improves insulin signaling. This mirrors the mechanism of metformin, though berberine also has additional targets.

In the gut, berberine stimulates GLP-1 (glucagon-like peptide-1) secretion from intestinal L-cells, contributing to improved glucose-dependent insulin secretion and appetite regulation. It also inhibits alpha-glucosidase and disaccharidase enzymes in the intestinal brush border, slowing carbohydrate digestion and glucose absorption. Berberine significantly modulates the gut microbiome, increasing beneficial bacteria (Akkermansia, Bifidobacterium) and reducing pathogenic species.

Additional mechanisms include inhibition of PCSK9 (increasing LDL receptor expression and LDL clearance), anti-inflammatory effects through NF-kB and MAPK pathway inhibition, and direct antimicrobial activity against a broad spectrum of bacteria, fungi, and protozoa. Berberine also inhibits adipogenesis and promotes brown adipose tissue thermogenesis, contributing to its metabolic benefits.

02

What to expect

Early
Days 1–7

Weeks 1-2: GI adjustment period. Blood glucose may begin to improve. Adapting to supplement.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

Primary safety: 34.5% of participants experienced transient gastrointestinal adverse effects.

During the trial, 20 (34.5%) patients experienced transient gastrointestinal adverse effects.

Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism: clinical and experimental · 2008 · PMID 18442638

Evidence scope. Human, type 2 diabetes patients (not healthy volunteers); trial-specific adverse-event rate, not a general-population figure.

Safety boundary: a clinical review reports very low toxicity at usual doses without major side effects.

Berberine has very low toxicity in usual doses and reveals clinical benefits without major side effects.

Berberine and barberry (Berberis vulgaris): A clinical review. Phytotherapy research : PTR · 2019 · PMID 30637820

Evidence scope. Human clinical review of 77 studies; general tolerability conclusion, not a formal toxicology determination.

Mechanism: anti-inflammatory actions include inhibition of cytokine production plus NF-kB and MAPK signaling.

The related pharmacological mechanisms of berberine anti-inflammation include the inhibition of inflammatory cytokine production (e.g., IL-1β, IL-6, TNF-α), thereby attenuating the inflammatory response; Inhibiting the activation of NF-κB signaling pathway and IκBα degradation; Inhibiting the activation of MAPK signaling pathway; Enhancing the activation of the STAT1 signaling pathway; Berberine interacts directly with cell membranes through a variety of pathways, thereby influencing cellular physiological activities.

Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024 · PMID 38522318

Evidence scope. Narrative review plus network pharmacology/molecular docking analysis; mechanism-only claim, mixes human and animal literature.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Card-specific “strong CYP3A4 inhibitor” interaction claim. No checked abstract directly supported that exact interaction statement for the displayed oral regimen.

Exact dose: 500 mg orally 2-3x/day with meals. The checked diabetes abstract does not state the berberine dose in a sentence; the 0.5 g three-times-daily parenthetical is attached to metformin and cannot be transferred to berberine.

04

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

Omega-3 Fatty AcidsComplementary lipid-lowering effects through different mechanisms (berberine via PCSK9, omega-3 via triglyceride synthesis reduction)
ProbioticsBerberine modulates gut microbiome while probiotics provide beneficial organisms - potentially complementary gut health effects
MetforminOverlapping AMPK activation but through different upstream mechanisms. Combination may allow lower doses of each. Must monitor blood glucose closely to avoid hypoglycemia
Alpha-Lipoic AcidBoth improve insulin sensitivity through complementary mechanisms - ALA via enhanced insulin signaling, berberine via AMPK/GLUT4

Keep separate

CYP3A4 Substrates (many medications)Berberine strongly inhibits CYP3A4 and CYP2D6, potentially increasing blood levels of many medications including statins, immunosuppressants, and antiarrhythmics
CyclosporineBerberine inhibits CYP3A4 and P-glycoprotein, significantly increasing cyclosporine levels - potentially dangerous interaction
Sulfonylureas/InsulinAdditive blood glucose lowering may cause hypoglycemia. If combining, monitor blood glucose closely and consider dose reduction of the pharmaceutical
Macrolide Antibiotics (azithromycin, clarithromycin)Both inhibit CYP3A4 - combined use may cause excessive drug accumulation and QT prolongation risk

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

05

Pharmacokinetics

Illustrative plasma concentration · 12 h
Half-life
~2-3 hours

(berberine), though gut-level effects persist longer

Peak · Tmax
~1-2 hours

Oral

Elimination
~12-18 hours

Parent compound and metabolites

Bioavailability
~5%

Oral (extensive first-pass metabolism and P-glycoprotein efflux). Gut-level concentrations are much higher than systemic.

Duration of action

Blood glucose effects: 4-8 hours per dose (hence 2-3x daily dosing with meals). AMPK activation effects accumulate with chronic dosing.

Clearance

Hepatic (CYP2D6, CYP3A4, CYP1A2 metabolism to demethyleneberberine and other metabolites). Biliary and renal excretion.

Storage. Store at room temperature (20-25C) in a cool, dry place. Protect from light and moisture. Capsules are shelf-stable for 2+ years. Powder form may clump with moisture exposure.

06

Regulatory status

Classified as a dietary supplement in the US (not FDA-approved for any medical condition). Not a prescription drug. Widely available over the counter. Used as an approved pharmaceutical for type 2 diabetes in China. Significant drug interaction potential - consult pharmacist if taking other medications.

Put it to work

Calculate, log & track

Open Berberine straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Berberine in the app →

Go deeper

The guide & community

The complete Berberine walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.